Alan W Sims

Alan W. Sims serves as a Contract Specialist responsible for managing the full lifecycle of federal acquisitions, from market research and solicitation development to contract award and administration. He plays a critical role in ensuring compliance with the Federal Acquisition Regulation (FAR) and promoting efficient, transparent procurement practices. His portfolio primarily encompasses complex scientific, technical, and pharmaceutical-related procurements, requiring deep subject matter expertise and meticulous contract structuring. Sims routinely handles competitive sealed bids, negotiated acquisitions, and task-order contracts under indefinite-delivery/indefinite-quantity (IDIQ) vehicles, ensuring alignment with agency mission needs and regulatory requirements. While specific contractor names are not publicly available, Sims maintains relationships with a diverse range of vendors, including large prime contractors in the life sciences and analytical instrumentation sectors, as well as small businesses capable of delivering specialized technical services. His contracting patterns reflect a preference for open competition, with the majority of awards conducted under unrestricted solicitations. He engages with vendors possessing strong quality control systems, ISO certifications, and validated laboratory capabilities, fostering partnerships grounded in technical rigor and regulatory compliance. Sims demonstrates a strong orientation toward unrestricted competition, with 93.7% of his awards issued without set-aside restrictions. Nevertheless, he actively supports small business participation, with approximately 4.8% of awards designated as Total Small Business Set-Asides under FAR 19.5 and 1.6% awarded through 8(a) competed contracts. His approach balances broad market access with targeted socioeconomic goals, ensuring equitable opportunities for qualified small businesses while maintaining program integrity and mission readiness. His procurement focus is concentrated in NAICS 325412 (Pharmaceutical Preparation Manufacturing), reflecting expertise in drug formulation, sterile compounding, and GMP-compliant production. He also frequently procures services under NAICS 541990 and 541712, encompassing research and development in physical and life sciences, as well as analytical laboratory instrumentation under NAICS 334516. This technical specialization underscores his proficiency in managing high-complexity, science-driven acquisitions requiring stringent regulatory adherence and technical validation.